-
Pharmaceutical Intermediates |Immunology |Peptide synthesis |Natural Amino Acid |Fmoc-N-Me-Trp(Boc)-OH |Nhamba yeCAS:197632-75-0
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synthesis |Natural Amino Acid |Fmoc-N-Me-Trp(Boc)-OH |CAS:197632-75-0 |C32H32N2O6
-
Pharmaceutical Intermediates |Immunology |Peptide synthesis |Fmoc-Trp-OH |CAS Nha.:35737-15-6 |C26H22N2O4
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synthesis |Natural Amino Acid |Fmoc-Trp-OH |CAS:35737-15-6 |C26H22N2O4
-
Pharmaceutical Intermediates |Immunology |Peptide synthesis |Fmoc-Yake(Trt)-OH |CAS Nha.:109425-51-6 |C40H33N3O4
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synthesis |Natural Amino Acid |Fmoc-Yake(Trt)-OH |CAS:109425-51-6 |C40H33N3O4
-
Pharmaceutical Intermediates |Immunology |Peptide synthesis |Fmoc-Ls(Boc)-OH |Nhamba yeCAS:71989-26-9
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synthesis |Natural Amino Acid |Fmoc-Ls(Boc)-OH |CAS:71989-26-9 |C26H32N2O6
-
Fmoc-D-Trp(Boc)-OH 163619-04-3
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synthesis |Natural Amino Acid |Fmoc-D-Trp(Boc)-OH |CAS:163619-04-3 |C31H30N2O6
-
Pharmaceutical Intermediates |Zvirwere zvekufema |Pranlukast Intermediates |3'-Acetylamino-2′-hydroxyacetophenone |CAS No.103205-33-0
Nyanzvi yekugadzira uye kupa biopharmaceutical |Pharmaceutical Intermediates Reagents |Raw materials |Zvirwere zvekufema |Pranlukast Intermediates |3'-Acetylamino-2′-hydroxyacetophenone |CAS:103205-33-0 |C10H11NO3
-
Pharmaceutical Intermediates |Dabigatran Intermediates |N-(4-CYANO-PHENYL)-GLYCINE |CAS No.42288-26-6
Nyanzvi yekugadzira uye kupa biopharmaceutical |Pharmaceutical Intermediates Reagents |Raw materials |Anticoagulant API |Dabigatran Intermediates |N-(4-CYANO-PHENYL)-GLYCINE |CAS:42288-26-6 |C9H8N2O2
-
Pharmaceutical Intermediates |Integrin antagonist |Lifitegrast Intermediates |3-Bromo-L-phenylalanine |CAS No.82311-69-1
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates |Lifitegrast Intermediates |3-Bromo-L-phenylalanine |CAS:82311-69-1 |C9H10BrNO2
-
Pharmaceutical Intermediates |Integrin antagonist |Lifitegrast Intermediates |Boc-3-bromo-L-phenylalanine |CAS No.82278-73-7
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates |Integrin antagonist |Lifitegrast Intermediates |Boc-3-bromo-L-phenylalanine |CAS:82278-73-7 |C14H18BrNO4
-
Pharmaceutical Raw Material uye Intermediates |Chirwere cheshuga |(R) -3-Aminopiperidine dihydrochloride |CAS No.334618-23-4
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Active Pharmaceutical Ingredient Intermediates |Chirwere cheshuga |(R) -3-Aminopiperidine dihydrochloride |CAS:334618-23-4 |C5H14Cl2N2
-
Pharmaceutical Intermediates |(R)-1-Boc-3-Aminopiperidine |Chirwere cheshuga |CAS:188111-79-7
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Pharmaceutical Intermediates |(R)-1-Boc-3-Aminopiperidine |CAS:188111-79-7 |C10H20N2O2
-
Raw Materials |Pharmaceutical Intermediates |Cardiovascular |Zvirwere |(S)-(-)-Indoline-2-carboxylic acid |CAS No.79815-20-6
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Cardiovascular Diseases |High Blood Pressure |(S)-(-)-Indoline-2-carboxylic acid |CAS:79815-20-6 |C9H9NO2